239 related articles for article (PubMed ID: 20679634)
1. OAS1: a multiple sclerosis susceptibility gene that influences disease severity.
O'Brien M; Lonergan R; Costelloe L; O'Rourke K; Fletcher JM; Kinsella K; Sweeney C; Antonelli G; Mills KH; O'Farrelly C; Hutchinson M; Tubridy N
Neurology; 2010 Aug; 75(5):411-8. PubMed ID: 20679634
[TBL] [Abstract][Full Text] [Related]
2. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
Fedetz M; Matesanz F; Caro-Maldonado A; Fernandez O; Tamayo JA; Guerrero M; Delgado C; López-Guerrero JA; Alcina A
Tissue Antigens; 2006 Nov; 68(5):446-9. PubMed ID: 17092260
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of polymorphisms in OAS1 with susceptibility and severity of hand, foot and mouth disease.
Cai Y; Chen Q; Zhou W; Chu C; Ji W; Ding Y; Xu J; Ji Z; You H; Wang J
Int J Immunogenet; 2014 Oct; 41(5):384-92. PubMed ID: 25059424
[TBL] [Abstract][Full Text] [Related]
4. 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.
Mandal S; Abebe F; Chaudhary J
Cancer; 2011 Dec; 117(24):5509-18. PubMed ID: 21638280
[TBL] [Abstract][Full Text] [Related]
5. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan.
Imran M; Manzoor S; Khattak NM; Tariq M; Khalid M; Javed F; Bhatti S
Viral Immunol; 2014 Apr; 27(3):105-11. PubMed ID: 24673406
[TBL] [Abstract][Full Text] [Related]
6. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
[TBL] [Abstract][Full Text] [Related]
7. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
He J; Feng D; de Vlas SJ; Wang H; Fontanet A; Zhang P; Plancoulaine S; Tang F; Zhan L; Yang H; Wang T; Richardus JH; Habbema JD; Cao W
BMC Infect Dis; 2006 Jul; 6():106. PubMed ID: 16824203
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.
Vosslamber S; van der Voort LF; van den Elskamp IJ; Heijmans R; Aubin C; Uitdehaag BM; Crusius JB; van der Pouw Kraan TC; Comabella M; Montalban X; Hafler DA; De Jager PL; Killestein J; Polman CH; Verweij CL
Genes Immun; 2011 Sep; 12(6):466-72. PubMed ID: 21471993
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis.
Carrasco-Campos MI; Pérez-Ramírez C; Macías-Cortés E; Puerta-García E; Sánchez-Pozo A; Arnal-García C; Barrero-Hernández FJ; Calleja-Hernández MÁ; Jiménez-Morales A; Cañadas-Garre M
Mol Neurobiol; 2021 Sep; 58(9):4716-4726. PubMed ID: 34169444
[TBL] [Abstract][Full Text] [Related]
10. [
Yaping LI; Song Z; Wenjun W; Huiling D; Mei LI; Xiaoli J; Shuangsuo D
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):381-386. PubMed ID: 31068279
[TBL] [Abstract][Full Text] [Related]
11. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
Field LL; Bonnevie-Nielsen V; Pociot F; Lu S; Nielsen TB; Beck-Nielsen H
Diabetes; 2005 May; 54(5):1588-91. PubMed ID: 15855350
[TBL] [Abstract][Full Text] [Related]
12. [A case-control study on association between OAS1 polymorphism and susceptibility to spontaneous preterm birth and preterm premature rupture of membranes].
Yang X; Zhang XA; Wu ZH; Peng W; Zhu LN; Wang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):898-902. PubMed ID: 26412166
[TBL] [Abstract][Full Text] [Related]
13. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.
Zhao Y; Kang H; Ji Y; Chen X
Clin Exp Med; 2013 Aug; 13(3):171-6. PubMed ID: 22710942
[TBL] [Abstract][Full Text] [Related]
14. Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Malhotra S; Morcillo-Suárez C; Nurtdinov R; Rio J; Sarro E; Moreno M; Castilló J; Navarro A; Montalban X; Comabella M
Eur J Neurol; 2013 Oct; 20(10):1390-7. PubMed ID: 23700969
[TBL] [Abstract][Full Text] [Related]
15. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Cantó E; Reverter F; Morcillo-Suárez C; Matesanz F; Fernández O; Izquierdo G; Vandenbroeck K; Rodríguez-Antigüedad A; Urcelay E; Arroyo R; Otaegui D; Olascoaga J; Saiz A; Navarro A; Sanchez A; Domínguez C; Caminero A; Horga A; Tintoré M; Montalban X; Comabella M
Mult Scler; 2012 Jul; 18(7):983-90. PubMed ID: 22183936
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
[TBL] [Abstract][Full Text] [Related]
17. [Long term effect of interferon-beta on disease severity in relapsing-remitting multiple sclerosis patients].
Patrucco L; Rojas JI; Cristiano E
Rev Neurol; 2010 May; 50(9):529-32. PubMed ID: 20443171
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
Patti F; Amato MP; Bastianello S; Caniatti L; Di Monte E; Ferrazza P; Goretti B; Gallo P; Morra VB; Lo Fermo S; Picconi O; Tola MR; Trojano M;
Mult Scler; 2010 Jan; 16(1):68-77. PubMed ID: 19995846
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide variants in the
Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
